BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 34500808)

  • 1. Heteroleptic Oxidovanadium(V) Complexes with Activity against Infective and Non-Infective Stages of
    Scalese G; Machado I; Salinas G; Pérez-Díaz L; Gambino D
    Molecules; 2021 Sep; 26(17):. PubMed ID: 34500808
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New heteroleptic oxidovanadium(V) complexes: synthesis, characterization and biological evaluation as potential agents against Trypanosoma cruzi.
    Scalese G; Machado I; Fontana C; Risi G; Salinas G; Pérez-Díaz L; Gambino D
    J Biol Inorg Chem; 2018 Dec; 23(8):1265-1281. PubMed ID: 30194536
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oxidovanadium(IV) and dioxidovanadium(V) complexes of tridentate salicylaldehyde semicarbazones: searching for prospective antitrypanosomal agents.
    Fernández M; Becco L; Correia I; Benítez J; Piro OE; Echeverria GA; Medeiros A; Comini M; Lavaggi ML; González M; Cerecetto H; Moreno V; Pessoa JC; Garat B; Gambino D
    J Inorg Biochem; 2013 Oct; 127():150-60. PubMed ID: 23528424
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expanding the family of heteroleptic oxidovanadium(IV) compounds with salicylaldehyde semicarbazones and polypyridyl ligands showing anti-Trypanosoma cruzi activity.
    Scalese G; Benítez J; Rostán S; Correia I; Bradford L; Vieites M; Minini L; Merlino A; Coitiño EL; Birriel E; Varela J; Cerecetto H; González M; Pessoa JC; Gambino D
    J Inorg Biochem; 2015 Jun; 147():116-25. PubMed ID: 25824466
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A new series of heteroleptic oxidovanadium(IV) compounds with phenanthroline-derived co-ligands: selective Trypanosoma cruzi growth inhibitors.
    Fernández M; Varela J; Correia I; Birriel E; Castiglioni J; Moreno V; Costa Pessoa J; Cerecetto H; González M; Gambino D
    Dalton Trans; 2013 Sep; 42(33):11900-11. PubMed ID: 23787783
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heteroleptic oxidovanadium(IV) complexes of 2-hydroxynaphtylaldimine and polypyridyl ligands against Trypanosoma cruzi and prostate cancer cells.
    Scalese G; Mosquillo MF; Rostán S; Castiglioni J; Alho I; Pérez L; Correia I; Marques F; Costa Pessoa J; Gambino D
    J Inorg Biochem; 2017 Oct; 175():154-166. PubMed ID: 28755573
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of Fluorination on the Structure and Anti-
    Salsi F; Bulhões Portapilla G; Simon S; Roca Jungfer M; Hagenbach A; de Albuquerque S; Abram U
    Inorg Chem; 2019 Aug; 58(15):10129-10138. PubMed ID: 31310108
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New oxidovanadium(IV) N-acylhydrazone complexes: promising antileishmanial and antitrypanosomal agents.
    Benítez J; Cavalcanti de Queiroz A; Correia I; Alves MA; Alexandre-Moreira MS; Barreiro EJ; Lima LM; Varela J; González M; Cerecetto H; Moreno V; Pessoa JC; Gambino D
    Eur J Med Chem; 2013 Apr; 62():20-7. PubMed ID: 23353731
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vanadium polypyridyl compounds as potential antiparasitic and antitumoral agents: new achievements.
    Benítez J; Becco L; Correia I; Leal SM; Guiset H; Pessoa JC; Lorenzo J; Tanco S; Escobar P; Moreno V; Garat B; Gambino D
    J Inorg Biochem; 2011 Feb; 105(2):303-12. PubMed ID: 21194632
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel coumarins active against Trypanosoma cruzi and toxicity assessment using the animal model Caenorhabditis elegans.
    Soares FGN; Göethel G; Kagami LP; das Neves GM; Sauer E; Birriel E; Varela J; Gonçalves IL; Von Poser G; González M; Kawano DF; Paula FR; de Melo EB; Garcia SC; Cerecetto H; Eifler-Lima VL
    BMC Pharmacol Toxicol; 2019 Dec; 20(Suppl 1):76. PubMed ID: 31852548
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Do bioactive 8-hydroxyquinolines oxidovanadium(IV) and (V) complexes inhibit the growth of M. smegmatis?
    Scalese G; Arhouma Z; Kostenkova K; Pérez-Díaz L; Crick DC; Gambino D; Crans DC
    J Inorg Biochem; 2022 Dec; 237():111984. PubMed ID: 36152468
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of new dinuclear Fe(III) coordination compounds with
    Moreira FF; Portes JA; Barros Azeredo NF; Fernandes C; Horn A; Santiago CP; Segat BB; Caramori GF; Madureira LMP; Candela DRS; Marques MM; Lamounier Camargos Resende JA; de Souza W; DaMatta RA; Seabra SH
    Dalton Trans; 2021 Sep; 50(35):12242-12264. PubMed ID: 34519725
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design of vanadium mixed-ligand complexes as potential anti-protozoa agents.
    Benítez J; Guggeri L; Tomaz I; Arrambide G; Navarro M; Pessoa JC; Garat B; Gambino D
    J Inorg Biochem; 2009 Apr; 103(4):609-16. PubMed ID: 19091422
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rhenium(I) tricarbonyl compounds of bioactive thiosemicarbazones: Synthesis, characterization and activity against Trypanosoma cruzi.
    Rodríguez Arce E; Machado I; Rodríguez B; Lapier M; Zúñiga MC; Maya JD; Olea Azar C; Otero L; Gambino D
    J Inorg Biochem; 2017 May; 170():125-133. PubMed ID: 28237731
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dual Parasiticidal Activities of Phthalimides: Synthesis and Biological Profile against Trypanosoma cruzi and Plasmodium falciparum.
    Teixeira de Moraes Gomes PA; Veríssimo de Oliveira Cardoso M; Dos Santos IR; Amaro de Sousa F; da Conceição JM; Gouveia de Melo Silva V; Duarte D; Pereira R; Oliveira R; Nogueira F; Alves LC; Brayner FA; da Silva Santos AC; Rêgo Alves Pereira V; Lima Leite AC
    ChemMedChem; 2020 Nov; 15(22):2164-2175. PubMed ID: 32813331
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of 2-hydroxy-3-phenylsulfanylmethyl-[1,4]-naphthoquinone derivatives against different Trypanosoma cruzi discrete type units: Identification of a promising hit compound.
    Lara LS; Moreira CS; Calvet CM; Lechuga GC; Souza RS; Bourguignon SC; Ferreira VF; Rocha D; Pereira MCS
    Eur J Med Chem; 2018 Jan; 144():572-581. PubMed ID: 29289882
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trypanocidal activity of 5,6-dihydropyran-2-ones against free trypomastigotes forms of Trypanosoma cruzi.
    de Fátima A; Marquissolo C; de Albuquerque S; Carraro-Abrahão AA; Pilli RA
    Eur J Med Chem; 2006 Oct; 41(10):1210-3. PubMed ID: 16815596
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multi-target heteroleptic palladium bisphosphonate complexes.
    Cipriani M; Rostán S; León I; Li ZH; Gancheff JS; Kemmerling U; Olea Azar C; Etcheverry S; Docampo R; Gambino D; Otero L
    J Biol Inorg Chem; 2020 May; 25(3):509-519. PubMed ID: 32232584
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro and in vivo trypanocidal evaluation of nickel complexes with an azapurine derivative against Trypanosoma cruzi.
    Maldonado CR; Marín C; Olmo F; Huertas O; Quirós M; Sánchez-Moreno M; Rosales MJ; Salas JM
    J Med Chem; 2010 Oct; 53(19):6964-72. PubMed ID: 20812723
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improving the drug-likeness of inspiring natural products - evaluation of the antiparasitic activity against Trypanosoma cruzi through semi-synthetic and simplified analogues of licarin A.
    Morais TR; Conserva GAA; Varela MT; Costa-Silva TA; Thevenard F; Ponci V; Fortuna A; Falcão AC; Tempone AG; Fernandes JPS; Lago JHG
    Sci Rep; 2020 Mar; 10(1):5467. PubMed ID: 32214193
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.